We are live on ! Find out more
ATEX icon

Anterix

88 hedge funds and large institutions have $515M invested in Anterix in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,514% more call options, than puts

Call options by funds: $2.72M | Put options by funds: $59K

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

1.65% more ownership

Funds ownership: 80.79%82.44% (+1.6%)

4% more capital invested

Capital invested by funds: $494M → $515M (+$21.2M)

3% less funds holding

Funds holding: 9188 (-3)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
88
Holders Change
-3
Holders Change %
-3.3%
% of All Funds
1.4%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
4
Increased
37
Reduced
24
Closed
6
Calls
$2.72M
Puts
$59K
Net Calls
+$2.66M
Net Calls Change
+$573K

ATEX Hedge Fund Activity: Q1 2023 in Review

88 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Anterix (ATEX) for Q1 2023, worth a combined $515M — up 4.3% from $494M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ATEX and 4 opened new positions — a net loss of 2 holders — while 24 trimmed existing stakes and 37 added.

The largest buyer was Heard Capital LLC, adding an estimated $6.9M. The largest seller was Morgan Stanley, cutting an estimated $21.1M.

  • 88 institutional investors held Anterix (ATEX) as of Q1 2023, down from 91 in Q4 2022.
  • Funds reported $515M of Anterix stock for Q1 2023, up 4.3% quarter-over-quarter.
  • 4 funds opened new Anterix positions in Q1 2023 and 6 closed out, a net change of -2 holders.
  • The largest Anterix buyer in Q1 2023 was Heard Capital LLC, an estimated $6.9M added.
  • The largest Anterix seller in Q1 2023 was Morgan Stanley, an estimated $21.1M sold.

Based on aggregated 13F filings for Q1 2023.